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Purpose: Unequivocal indications for renal artery reconstruction remain the presence of 
significant underlying renal insufficiency or severe hypertension. Thus surgical interven- 
tion for renal artery stenosis in the absence of this clinical picture may well be considered 
empirical and, as a consequence, treatment recommendations are ill-defined. Our 
experience with reconstruction fthe minimally symptomatic orasymptomatic renal artery 
lesion in association with primary aortic repair over a 10-year period was reviewed. 
Methods: Thirty-two patients who had atherosclerotic renal artery stenosis _>70% under- 
went prophylactic renal revascularization between 1982 and 1992. The patients' median 
age was 63 years (range, 44 to 79 years); 23 (72%) were men and nine (28%) were women. 
All had preoperative s rum creatinine levels _<1.7 mg/dl  (1.29 + 0.24 mg/dl)  and were 
receiving either no antihypertensive medication (22%) or only a single agent (78%). 
Aortoiliac occlusive disease was present in 38% of this population, and aortic aneurysmal 
disease ither alone or in combination with occlusive disease was found in 62%. 
Results: Operative management i cluded unilateral renal artery repair in 21 patients (66%) 
andbilateral renal revascularization in the remaining 11 (34%). The median decrease in 
postoperative s rum creatinine level (->7 days after operation) was 0.81 _+ 0.05% (mean 
postoperative s rum creatinine l vel, 1.27 + 0.07 mg/dl). The 30-day operative mortality 
rate was 3.1% (1 of 32 ). Late follow-up was available for 96% of patients (30 of 31; median, 
64 months). Kaplan-Meier life table analysis revealed a 5-year probability of survival of 
90.2% (95% confidence interval, 0.802 to 1.00). Stability ofrenal function was assessed by 
modeling the change in serum creatinine level over time with the intraclass correlation 
model. A serum creatinine level (mg/dl) = 1.3348 + 0.0011 x time (months) demon- 
strated minimal deterioration of excretory fimction during the observation period. 
Furthermore, the blood pressure of the majority of patients (75%) remained normal either 
with a single agent or without medication. Recurrent stenosis in one patient required 
treatment by percutaneous transluminal ngioplasty. 
Conclusions: Adjunctive repair of the renal artery may be an appropriate option in selected 
patients who undergo simultaneous aortic surgery, even in the absence of severe 
hypertension or renal insufficiency. Surgical intervention can be accomplished with 
acceptable p rioperative morbidity rates, and stability of renal function is sustainable inthe 
majority of patients. (J Vasc Surg 1996:24:406-14.) 
Severe hypertension and renal insufficiency in 
association with atherosclerotic renal artery occlusive 
disease are unequivocal indications for renal revascu- 
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larization. It  is accepted that the benefit of  surgical 
intervention i  this population, although not always 
uniform, is nonetheless well established for a majority 
of patients. Although the severity of functional im- 
pairment necessary to recommend renal artery repair 
has not been precisely defined, a serum creatinine 
level greater than 1.7 mg/d l  or the requirement of 
multiple antihypertensive medications have been 
cited in the literature) -4This clinical picture is often 
emphasized because current screening studies are 
often incapable of determining whether enovascular 
disease is, in fact, the dominant underlying cause of a 
patient's hypertension or renal insufficiency. This 
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limitation is particularly observed in the increasingly 
prevalent presentation of generalized atherosclerosis 
with bilateral renal artery disease. Thus repair of the 
lesion in the absence of this clinical presentation or a 
definitive functional test may well be considered 
empirical .and remains controversial. 
The dominant view now holds that only a minority 
of patients who have initially silent or minimally 
symptomatic lesions would derive benefit from inter- 
vention. In the past, these arguments have been based 
on the lack of prospective data regarding the natural 
history of the atherosclerotic renal artery, the signifi- 
cant, though modest, functional decline in only a 
proportion of patients with renovascular hyperten- 
sion, and the anticipated added perioperative morbid- 
ity and mortality rates. This risk-benefit ratio would 
be further reduced by the potential requirement for 
subsequent late reintervention for failed or failing 
repair. Undeniably, given the data available during the 
past two decades, prudence would dictate a cautious 
stance to the advocacy of an overly aggressive ap- 
proach toward repair of the functionally benign renal 
artery lesion. 
Although more contemporary data have expressly 
challenged many of these assumptions, two issues 
have been highlighted in recent years, both within and 
outside the area of renovascular disease, that provide 
added perspective to this debate. First, there is little 
doubt that the clinical spectrum of renovascular 
disease currently treated by the vascular surgeon has 
shifted dramatically from the presentation of poorly 
controlled hypertension, predominant in the 1970s, 
to that of renal insufficiency, which characterizes the 
majority of our patients in the 1990s. 1,2,4-8 In this 
regard, there is little data to substantiate a fundamen- 
tal change in the underlying disease process or the 
introduclaion of a diagnostic technique that has led to 
an improvement in our ability to recognize this new 
entity of ischemic ncphropathy. Rather, significant 
improvements in the medical management ofhyper- 
tension have more than likely contributed to delayed 
recognition of a surgically treatable l sion, ultimately 
with adverse clinical effects. In this scenario, long- 
term undetected chronic ischemia produces a mea- 
surable deterioration in renal function. Thus the 
suitability of intervention thatwas largely dictated in 
the past by the number of required antihypertensive 
agents eems an inappropriate standard for modern 
care. Second, the benefits of repair of an atheroscle- 
rotic lesion within the context of asymptomatic ca- 
rotid artery disease have been demonstrated convinc- 
ingly in recent randomized prospective tr ia ls.  9'1° Al- 
though such an analysis has yet to be performed for 
renovascular disease, these studies have established an 
initial framework for the decisionmaking process that 
is required for surgical treatment of the potentially 
benign renal artery lesion. Specifically, when the 
margin of risks and benefits is small, justification for 
repair mandates a perioperative morbidity and mor- 
tality rate that is acceptably low, a life expectancy 
suitably long to achieve the derived benefit, and a 
repair sufficiently durable to minimize the need for 
reintervention. 
The combination of minimally symptomatic or 
asymptomatic renovascuiar stenosis in association 
with aortic disease is particularly pertinent because 
simultaneous renal and aortic disease is observed in 
between 30% and 40% of all patients, n Many of these 
patients, however, do not meet he currently accepted 
clinical indications for repair of the renovascular 
lesion. Justification for the initiation of prospective 
trials and their design rationale will require baseline 
data regarding early and late outcome. Thus our 
experience with surgical reconstruction of the renal 
artery when combined with aortic repair was reviewed 
among those patients who came to our service with- 
out severe preoperative hypertension or significant 
renal insufficiency. 
MATERIALS AND METHODS 
Patient population. A retrospective analysis of all 
patients who underwent combined aortic reconstruc- 
tion and renal revascuiarization at Emory University 
Hospital between January 1982 and March 1992 was 
performed. In general, stenoses >70% were addressed 
in stable patients who had life expectancies ofseveral 
years. The selection criteria included a serum creati- 
nine level of 1.7 mg/dl or less at admission and the 
presence of either an abdominal aortic aneurysm or 
symptomatic aortoiliac occlusive disease. In all cases 
patients were receiving no more than a single antihy- 
pertensive agent. Patients were not included if the 
primary procedure that needed to be performed was 
the repair of a thoracoabdominal aneurysm. 
Data were collected with respect o (1) patient 
demographics, including cardiovascular risk factors, 
severity of renal disease, and angiographic findings; 
(2) operative management, complications, and early 
functional results; and (3) late functional status, 
including the need for subsequent intervention, as 
well as blood pressure response and survival. Long- 
term data were obtained from clinic or hospital 
records or by telephone interview with the patient, 
family, or primary physician. 
Definitions. The definitions of renal function, 
blood pressure response, and bilaterality of renovas- 
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Table I. Clinical characteristics of 
patient population 
Age (yr) 
Range 44 to 79 
Median 63 
Mean 63.3 
Sex 
Male 23 (72%) 
Female 9 (28%) 
Smoking 30 (92%) 
Diabetes mellitus 2 (6%) 
Hypertension 29 (91%) 
0 medications 7 (22%) 
1 medication 25 (78%) 
Preoperative ACE inhibitor 3 (9%) 
ASHD 27 (84%) 
Prior CABG/PTCA 13 (41%) 
Remote MI 12 (38%) 
Positive coronary angiogram 12 of 19 (63%) 
PVD 17 (53%) 
Claudication 12 (38%) 
Rest pain 1 (3%) 
Mesenteric insufficiency 3 (9%) 
CVD 15 (47%) 
Prior CEA 4 (13%) 
ACE, Angiotensin-converting e zyme; ASHD, arteriosderotic 
heart disease; CABG, coronary artery bypass grafting; PTCA, 
percutaneous transluminal angioplasty; MI, myocardial infarction; 
PVD, peripheral vascular disease; CVD, cerebrovascular disease; 
CEA, carotid endarterectomy. 
cular disease that were described by Dean and asso- 
ciates were used for our study. 2 Early postoperative 
renal function was assessed in terms of the serum 
creatinine level as measured 7 days or more after 
operation but before discharge. All subsequently 
available serum creatinine measurements were used to 
determine the stability of renal function over time. 
Blood pressure and antihypertensive medication 
requirements were determined at the time of last 
follow-up, at least 2 months after operative interven- 
tion. Patients were classified as having normal blood 
pressure based on the absence of antihypertensive 
medication and a diastolic blood pressure <95 mm 
Hg. For those patients who had a history of hyper- 
tension, improvement was defined by a decrease in 
diastolic pressure of_>20 mm Hg and no administra- 
tion of additional medication. Procedures were oth- 
erwise classified as failures. 
Renovascular disease was categorized asbilateral if 
there was either angiographically significant (>70%) 
bilateral occlusive disease or unilateral occlusive dis- 
ease in a true solitary lddney. Otherwise, patients were 
categorized as having unilateral disease. 
Statistical analysis. Long-term stability of renal 
function was determined by fitting separate linear 
regression lines for each person and performing 
Wilcoxon one-sample t sts on the resultant slopes to 
test the null hypothesis that the slope did not differ 
significantly from zero. Analysis was also confirmed by 
modeling serum creatinine level with the intraclass 
correlation model, which accounts for the correla- 
tions between measurements within individual pa- 
tients. This analysis was performed with the PROC 
MIXED program of the SAS statistical package. The 
probabilities of death over time were estimated with 
Kaplan-Meier analyses. 
Two sample ttests were used to detect associations 
between blood pressure control (improved or cured 
vs failed) and continuous variables. Significance was 
reevaluated with a Wilcoxon rank-sum test when 
necessary. The significance for categorical variables 
was analyzed with Fisher's exact est. 
RESULTS 
Preoperative patient profile. The clinical char- 
acteristics and angiographic data of our patient popu- 
lation are summarized in Tables I and II, respectively. 
Of note, at the time of operative intervention 25 
patients (78%) were taking a single prescribed antihy- 
pertensive medication. The remainder were not re- 
ceiving medication for blood pressure control. Only 
two of these seven patients, however, had normal 
blood pressure. Baseline renal function among mem- 
bers of the group was characterized bya preoperative 
serum creatinine l vel of l .29 _+ 0.24 mg/dl  (mean + 
standard error). Nonetheless, asdefined above, bilat- 
eral renal artery disease was present in more than half 
of the population. The study group represents ap- 
proximately 25% of all patients who underwent renal 
revascularization at Emory University Hospital dur- 
ing the review period. 
Operative management and early results. 
Methods of aortic and renal artery reconstruction a d 
postoperative complications are presented in Tables 
III and IV. Our preferred method of renal artery 
reconstruction in association with concomitant aortic 
repair has been bypass grafting with a 6-mm Dacron 
prosthesis. Intraoperative confirmation of the ad- 
equacy of surgical reconstruction was achieved with a 
continuous-wave Doppler flow probe. The most 
frequent postoperative complication, and the sole 
postoperative d ath, was related to underlying cardiac 
disease. The incidence of postoperative complications 
was not significantly higher among those patients who 
underwent bilateral procedures. The 30-day opera- 
tive mortality rate was 3.1% (1 of 32). 
The relationship between preoperative and post- 
operative serum creatinine l vels is presented inFig. 1. 
The median decrease in postoperative s rum creati- 
nine level (7 days after operation) was 0.81 + 0.05% 
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Table II. Angiographic data 
Abdominal aortic aneurysm 
Aortoiliac occlusive disease 
Combined aortic aneurysmal nd aortoiliac occlusive disease 
Isolated SMA stenosis or occlusion 
Combined SMA and celiac occlusive disease 
Unilateral renal artery disease 
Bilateral renal artery disease 
Bilateral renal artery occlusive disease 
Unilateral renal artery occlusive disease in a solitary renal artery 
3 (9%) 
12 (38%) 
17 (53%) 
i (3%) 
3 (9%) 
15 (47%) 
17 (53%) 
16 (50%) 
1- (3%) 
SMA, Superior mesenteric artery. 
*Indudes one patient who had a prior nephrectomy. 
Table I I I .  Operative treatment 
Methods of aortic reconstruction 
Aortobifemoral graft 
Aortobiiliac graft 
Aortic tube graft 
Methods of renal artery reconstruction 
Graft replacement ofaortic aneurysm 
Bilateral renal artery bypass 
Unilateral renal artery bypass 
Graft replacement ofaortic occlusive disease 
Bilateral renal artery bypass 
with reimplantarion f IMA 
with reimplantation f IMA, profundoplasty, and sympathectomy 
Unilateral renal artery bypass 
with reimplantation f IMA and celiac bypas 
with unilateral sympathectomy 
Graft replacement ofaortic aneurysm with occlusive disease 
Bilateral renal artery bypass 
with unilateral femoral thrombectomy 
with profandoplasty 
Unilateral revascularization 
with unilateral femoropopliteal bypass 
with SMA and 1MA reimplanted 
8 (25%) 
18 (56%) 
6 (19%) 
3 (9%) 
1 (3%) 
2 (6%) 
12 (38%) 
4 (13%) 
1 (3%) 
1 (3%) 
8 (25%) 
1 (3%) 
i (3%) 
17 (53%) 
6 (19%) 
1 (3%) 
1 (3%) 
11 (34%) 
i (3%) 
i (3%) 
IMA, Inferior mesenteric artery; SMA, superior mesentefic artery. 
(mean postoperative serum creatinine level, 1.27 + 
0.07 mg/dl).  Mild worsening of renal function (se- 
rum creafinine > 2.0 mg/dl) ,  however, was noted in 
three patients. One of these three represented the 
postoperative death in this series. In one of the 
surviving two patients, the serum creatinine l vel was 
1.7 mg/d l  at follow-up 56 months after surgery; the 
second was lost to follow-up. In all cases, unilateral 
renal artery repair was performed, and none of the 
patients required ialysis in the immediate postopera- 
tive period. Stratification with respect to the site of the 
disease (bilateral vs unilateral) did not reveal a pro- 
pensity for higher postoperative serum creatinine 
levels in one group when compared with another. 
Late functional outcome. Stability of renal func- 
tion beyond the postoperative p riod was assessed by 
analyzing the change in the serum creatinine level 
over time. As noted, separate linear regression lines 
were fitted for each patient. Sufficient data for this 
analysis were available for 25 patients. The mean and 
median number of postoperative serum crcatinine 
measurements for each studied patient were 6.3 and 
4, respectively. A graphic representation f  the distri- 
bution of slopes that represents he rate of change of 
the serum creatinine level over time is presented in 
Fig. 2. Wilcoxon testing did not reveal a significant 
difference of slopes from zero. The serum creatinine 
level also was modeled with the intraclass correlation 
model. A serum creatinine level (mg/dl)  = 1.3348 + 
0.0011 x time (months) demonstrated minimal de- 
terioration of excretory function during the observa- 
tion period. Standard error values for the intercept 
and slope were 0.0749 mg/d l  and 0.0007 months, 
respectively. The highest postoperative s rum creati- 
nine level was 2.6 mg/dl ,  and was observed 36 
months after bypasses were performed to both right 
upper- and lower-pole renal arteries. 
Late blood pressure status was evaluated in 28 
patients at a mean and median duration of follow-up 
of 43.3 and 38.5 months, respectively. Eight patients 
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Table IV. Postoperative complications 
Myocardial infarction 1 (3%) 
Atrial fibrillation 1 (3%) 
Death (arrhythmia) 1 (3%) 
Stroke I (3%) 
Atheroemboli requiring bilateral toe 1 (3%) 
amputations 
Thrombosis ofmesenteric graft 1 (3%) 
Thrombosis ofpopliteal aneurysm 1 (3%) 
Urinary retention 1 (3%) 
Prolonged ileus 2 (6%) 
(29%) had normal blood pressure without medica- 
tion, and an additional five patients (18%) were 
categorized as having improved from their preopera- 
tive status. Nine of the remaining 15 patients had an 
increment of at least one antihypertensive medica- 
tion. One patient was taking three agents for blood 
pressure control at the time of follow-up. Overall, the 
majority of patients (75%) maintained good blood 
pressure control either with a single agent or without 
medication. It is difficult to determine whether the 
added medication i the remaining 25% represented a 
significant deterioration i  blood pressure control or 
the inherent variability associated with the choice and 
number of antihypertensive agents. Statistically sig- 
nificant associations were not detected between blood 
pressure control and continuous or categoric vari- 
ables, including the anatomic lassification of renal 
disease as unilateral or bilateral. 
Renal angiograms or scans were not obtained on a 
routine basis during the study period. As a conse- 
quence, such data were available only in approxi- 
mately one half of the patients (14 of 31). None of the 
studies demonstrated graft occlusion. Three of the 
imaging studies, however, suggested persistent or 
recurrent renal artery stenosis. In one of these pa- 
tients, recurrent stenosis and worsening hypertension 
required treatment by percutaneous transluminal n- 
gioplasty. 
Late survival. Survival data were available for 96% 
of patients (30 of 31; median, 64 months). Kaplan- 
Meier life table analysis revealed a 5-year probability 
of survival of 90.2% (95% confidence interval, 0.802 
to 1.00). Eight late deaths occurred, the causes of 
which were heart disease (two patients), malignancy 
(two patients), stroke (one patient), or otherwise 
unknown (three patients). Of the patients whose 
cause of death was unknown, none was ascertained to
have an elevated serum creatinine l vel at the time of 
the last follow-up. The Kaplan-Meier survival func- 
tion is presented in Fig. 3. 
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Fig. 1. Relationship between preoperative and postopera- 
tive serum creatinine l vels. 
DISCUSSION 
The dictums of medicine--primum non nocere, 
first do no harm, and the corollary that intervention 
should yield a clear and durable benefit--have long 
been the established guidelines for justifying clinical 
treatment recommendations. Renal revascularization 
in the absence of a documented functional lesion 
remains aclinical dilemma because of the concern that 
insufficient data exist to confirm that we can achieve 
these minimum criteria. Nonetheless, both retrospec- 
tive and, more recently, prospective natural history 
studies have documented that the clinical course of 
atherosclerotic renovascular disease is one of gradual 
progression, often leading to worsening hypertension 
and renal insufficiency. For example, in a prospective 
analysis Zierler et al. 12 documented a 5% annual 
occlusion rate for lesions of >60% stenosis. Further- 
more, occlusion was associated with an average de- 
crease of nearly 2 cm in renal ength and an associated 
increase in diastolic blood pressure. Likewise, four 
other retrospective studies that used serial angiogra- 
phy over 10-year periods demonstrated anoverall rate 
of progression between 36% and 53%, often in asso- 
ciation with a decrease in renal size and function. 13-16 
In all reports, stenoses >60% appear to be at particu- 
larly high risk. Arguably, because the majority of 
patients included in these studies had hypertension, it 
is difficult o extrapolate hese data to determine the 
clinical significance of progressive disease for the truly 
silent lesion. Unfortunately, reliable clinical markers 
or tests for the assessment of renal collateral flow do 
not exist. Moreover, current reatment recommenda- 
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Fig. 3. Kaplan-Meier life table analysis of the study population. 
tions remain blurred for a growing number of our 
patients who, while not completely asymptomatic, do
not meet the standard criteria for intervention even 
when faced with the need for primary aortic repair. 
Poorly controlled renovascular hypertension, that 
which is in particular need of surgical intervention, 
has often been defined in terms of a requirement for 
multiple medications; however, increased effective- 
ness of the current generation of antihypertensive 
agents has improved our ability to achieve early 
adequate control and likely has reduced the total 
number of medications required. Furthermore, the 
growing number of reports regarding the potential 
renoprotective effects of antihypertensive therapy 
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may have provided the medical community with an 
undeserved sense of security. 17'18 Therefore, because 
angiographic or duplex imaging of the renal arteries 
remains largely guided by the adequacy of medical 
therapy, we should not be surprised that the propor- 
tion of patients who have undetected chronic renal 
ischemia has significantly increased. The impact of 
delayed recognition would be of relatively minor 
significance if worsening hypertension were the only 
concern. The more ominous consequence is the 
well-documented increase in the number of patients 
with ischemia-related renal insufficiency. 2,4-7 Preser- 
vation, and even improvement, in renal function is 
certainly observed after renal revascularization, par- 
ticularly in the face of a recent rapid decline in renal 
function. In the majority who have had a slow steady 
decline in function, however, the long-term results of 
operative intervention arc often less than optimal. A 
high rate of subsequent dialysis is especially prevalent 
in patients who have a preoperative s rum creatinine 
level greater than 3.0 mg/dl.  1,4,5 In turn, we have 
observed a significantly higher level of dialysis-free 
survival when intervention is instituted at an earlier 
point in the natural history of the disease, when 
function was only moderately compromised (serum 
creatinine level, 1.8 to 3.0 mg/dl).  4 If the lesion 
progresses to total occlusion, the opportunity for 
revascularization a d renal preservation is further 
compromised. 19 Because antihypertensive therapy 
provides mere symptomatic relief without signifi- 
cantly altering the course of the underlying renovas- 
cular disease, screening or treatment recommenda- 
tions based on the number of required medications 
would appear to be in need of revision. At the very 
least, a redefinition of what constitutes clinically 
justified indications for repair in the absence of a 
definitive functional test appears to be in order; 
otherwise, we should continue to expect o intervene 
when the stakes are higher and the anticipated out- 
come is poorer overall. 
The study population selected for review all had a 
serum creatinine l vel of 1.7 mg/dl  or less and before 
surgery were receiving no more than one antihyper- 
tensive agent. Although a very small proportion fell 
into the clinically silent category, most had associated 
hypertension, which is characteristic ofthe majority of 
patients with generalized atherosclerosis. As illus- 
trated in this report, bilateral renal artery involvement 
was present in one half of our population. Thus 
whether renovascular disease is, in fact, the underlying 
cause of hypertension is often difficult, if not impos- 
sible, to determine by current screening studies. For 
practical purposes, if aortic repair is required we see 
little reason to delay empirical renal artery repair 
simply because blood pressure control has been 
achieved with medical therapy. 
The underlying concern regarding concomitant 
renal and aortic surgery isthat a significant proportion 
of the treated population would not have otherwise 
progressed to clinically significant disease, and thus 
have incurred the risks of an unnecessary interven- 
tion. Similarly, until recently the treatment ofasymp- 
tomatic carotid disease has been controversial. Re- 
ports have documented that at the time of internal 
carotid artery occlusion as many as two thirds of all 
patients who were previously asymptomatic will not 
have a fixed neurologic deficit. 2° Therefore, in advo- 
cating endarterectomy for the >70% asymptomatic ca- 
rotid stenosis, we have implicitly accepted that a large 
proportion, and perhaps amajority, of patients would 
not have progressed to clinically significant disease in 
the absence of treatment. We have pursued this course 
because we are unable to determine which of these 
lesions will lead to a truly devastating outcome. 
Appropriately, several caveats can be raised in 
recommending repair of the stenotic renal artery., 
First, operative morbidity and mortality rates must be 
low to obtain the anticipated benefit in a sufficient 
proportion of patients. Several reports from centers of 
excellence now document that the addition of a renal 
bypass or endarterectomy to aortic surgery adds little 
risk of operative death or morbidity. 4'5'21-23 This is not 
to imply that such statistics can be uniformly achieved, 
but we bear responsibility for demonstrating that our 
personal results are acceptable. Second, long-term 
durability must be associated with the chosen inter- 
vention. It is acknowledged that the major limitation 
of the present study is the lack of comprehensive 
patency data. Nonetheless, large numbers of reports 
document the overall durability of renal artery bypass 
grafting, with 5-year patency rates approaching 
90%. 5,7,24.27 Certainly, endarterectomy is an accept- 
able alternative, with equally good results recently 
reported. 22,23,28,29 Finally, patient longevity must be 
sufficient to achieve the desired benefit. Typically, the 
5-year actuarial survival after combined aortic and 
renal artery surgery has ranged between 60% and 
75%. s-5"7 Coronary artery disease has been the pre- 
dominant cause of late death, and its association with 
renovascular disease has been recognized in these and 
other reports, s° Nonetheless, most studies have de- 
scribed patient groups from the 1980s or earlier. We 
would expect that in more contemporary analyses 
continued improvements in both the detection and 
treatment of coronary artery disease will have had a 
measurable positive impact on survival. As such, Rihal 
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et al. 31 demonstrated that coronary artery surgery 
appears to have a long-term survival benefit in patients 
who have peripheral vascular disease and triple-vessel 
coronary disease. The increased prevalence of under- 
lying renal insufficiency in association with renovas- 
cular disease is certainly an additional contributing 
factor to late death. Thus our 5-year survival rate of 
90% likely reflects the absence of both significant renal 
dysfunction and severe hypertension in an overall 
younger patient population, as well as the effects of 
coronary intervention. Regardless, given the natural 
history of progressive renovascular disease and the 
durability of renal function established in this report, 
benefit should be derived, particularly in patients who 
have bilateral disease. 
Watchfial waiting, with intervention at a later date 
as required, is with little doubt an acceptable course of 
action for patients who have a minimally symptomatic 
or asymptomatic renovascular lesion at the time of 
aortic surgery. The prospect of later surgery, however, 
carries with it the added morbidity, cost, and pro- 
longed recuperative period associated with the aging 
patient. Furthermore, the long-term success of an- 
gioplasty fiar bilateral renal artery orificial lesions is 
limited, and although the addition of metallic stents 
has been used to improve these results, restenosis may 
occur in as many as 30% to 40% of patients in less than 
1 year. s2-34 
CONCLUSION 
We have demonstrated that the repair of the 
"functionally benign" rcnovascular lesion in associa- 
tion with primary aortic repair can be accomplished 
with little incrcase in operative morbidity or mortality 
rates. Importantly, long-term renal function is sus- 
tained and benefit likely derivcd in a majority of 
patients, given both the high probability of 5-year 
survival and the prevalence of bilateral disease. We 
believe that the "unequivocal" indications for renal 
artery repair may be in need of redefinition. This 
considers that the shift in the clinical presentation of 
renovascular disease is a manifestation, at least in part, 
of changes in medical therapy and not a fundamental 
transformation of the underlying pathologic process. 
Finally, in the minority of patients who have a truly 
silent lesion, renal revascularization may be an appro- 
priate course if an acceptable level of operative risk can 
be ensured and reasonable life expectancy anticipated. 
The effort that has been required to decisively answer 
similar questions for carotid disease has been signifi- 
cant. Given the comparatively enhanced technical 
demands of renal artery surgery and the complexity of 
assessing long-term functional status, the ability to 
achieve a conclusive outcome in this area will be an 
even more challenging endeavor for the vascular 
community. 
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